603880 Share Price | Jiangsu Nanfang Medical Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.73%

Poor long term growth as Net Sales has grown by an annual rate of -12.05% and Operating profit at -191.83% over the last 5 years
The company is Net-Debt Free

The company has declared negative results in Jun'2026 after 2 consecutive positive quarters

Risky -

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 2,525 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

2.25

Return on Equity

-57.03%

Price to Book

14.67

Revenue and Profits:

Net Sales:

116 Million

(Quarterly Results - Jun 2026)

Net Profit:

-13 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

27.02%

6 Months

31.22%

1 Year

49.02%

2 Years

154.75%

3 Years

99.13%

4 Years

69.83%

5 Years

40.31%

Jiangsu Nanfang Medical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-12.05%

EBIT Growth (5y)

-191.83%

EBIT to Interest (avg)

-3.77

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

1.59

Sales to Capital Employed (avg)

0.74

Tax Ratio

7.65%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

2.75%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

11.82

EV to EBIT

-30.10

EV to EBITDA

-52.27

EV to Capital Employed

4.34

EV to Sales

4.14

PEG Ratio

Dividend Yield

ROCE (Latest)

-14.40%

ROE (Latest)

-57.03%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -25.34% vs 1.24% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -154.00% vs 93.45% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "115.80",
          "val2": "155.10",
          "chgp": "-25.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.50",
          "val2": "9.50",
          "chgp": "-63.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.60",
          "val2": "6.00",
          "chgp": "-23.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-12.70",
          "val2": "-5.00",
          "chgp": "-154.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-75.70%",
          "val2": "-18.00%",
          "chgp": "-5.77%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -0.45% vs 1.38% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 46.93% vs -29.33% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "598.60",
          "val2": "601.30",
          "chgp": "-0.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-35.30",
          "val2": "-86.60",
          "chgp": "59.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "22.10",
          "val2": "26.50",
          "chgp": "-16.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-38.40",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-101.10",
          "val2": "-190.50",
          "chgp": "46.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-137.20%",
          "val2": "-235.60%",
          "chgp": "9.84%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]